Klinik Hirslanden Zurich

Klinik Hirslanden in Zurich provides broad inpatient and outpatient care with surgical, maternity, cardiovascular and diagnostic infrastructure. The hospital publishes its own annual capacity and physician figures, and its tumor center participates in organized clinical research.

The hospital's own annual figures cover the financial year from April 2025 to March 2026. They distinguish inpatient and maternity activity, emergency admissions, outpatient consultations, newborns, professional staff and trainees. The physician category includes partner and employed doctors, while the employee total shown alongside it excludes employed physicians. These are different workforce measures and are not added together as though they were the same category.

The published infrastructure includes fourteen operating rooms, three delivery rooms and five cardiac-catheterization laboratories. Diagnostic equipment is reported separately: computed tomography, magnetic resonance and nuclear-medicine facilities are identified in the medical-infrastructure directory. The same directory lists intraoperative radiotherapy, linear accelerators, Da Vinci surgical systems and CyberKnife. This is an equipment inventory for the hospital, not a statement that every consultation involves these technologies.

The clinical organization combines scheduled specialist assessment with hospital treatment, surgery, maternity and emergency services. A dedicated intensive-care service is identified within the hospital's operative and intervention infrastructure. The source's description of access refers to patients from different insurance classes; that statement should not be confused with a guarantee that a particular insurer covers every procedure or accommodation category.

The Zurich Tumor Center describes clinical research as part of its institutional activity. Its official information discusses investigation of treatment doses, effects, unwanted effects and quality of life, and identifies cooperation through international study groups. The center also publishes information about available studies. These are defined research activities, separate from the wider hospital's annual patient and equipment statistics.

The reporting gives visibility to education as well as treatment, distinguishing students and apprentices from employees and physicians. The resulting institutional picture is that of a specialist hospital with a substantial operative and diagnostic platform, maternity services, critical-care support and an organized oncology-research setting. Each numerical figure remains attached to Klinik Hirslanden itself and to the reporting period, rather than being borrowed from another hospital in the Hirslanden group.

The institution reports the following clinical and infrastructure information: outpatient care: Yes; inpatient beds: 335 (Financial year 2025/2026.); doctors: 725 (Partner and employed doctors, 2025/2026.); intensive care / resuscitation: Yes. The scope and reporting period remain those of the linked institutional sources.

The Hirslanden Zurich Tumor Center publishes information about clinical research and a list of open studies. Its official description discusses assessment of treatment doses, effects, side effects and quality of life, and collaboration through international study groups.